Fatty Alcohol Synthesis and Virulence in Leishmania

Information

  • Research Project
  • 8853768
  • ApplicationId
    8853768
  • Core Project Number
    SC3GM113743
  • Full Project Number
    1SC3GM113743-01
  • Serial Number
    113743
  • FOA Number
    PAR-14-018
  • Sub Project Id
  • Project Start Date
    4/1/2015 - 9 years ago
  • Project End Date
    3/31/2019 - 5 years ago
  • Program Officer Name
    KRASNEWICH, DONNA M
  • Budget Start Date
    4/1/2015 - 9 years ago
  • Budget End Date
    3/31/2016 - 8 years ago
  • Fiscal Year
    2015
  • Support Year
    01
  • Suffix
  • Award Notice Date
    3/25/2015 - 9 years ago

Fatty Alcohol Synthesis and Virulence in Leishmania

? DESCRIPTION (provided by applicant): Leishmania species are protozoan parasites that cause important human diseases in the tropics and subtropics worldwide and, thus, represent a major public health problem. Ether lipids are important constituents of Leishmania membranes, and more importantly, are structural components of various virulence factors, such as the very abundant cell surface lipophosphoglycan and the glycosylphosphatidylinositol(GPI)-anchored protease GP63. Both play crucial roles during the entire life cycle of the parasite. Ether lipid-based drugs such as miltefosine, currently used in clinical trials, inhibit parasite growth in vitr and in vivo, and are likely to interfere with the ether lipid biosynthetic pathway. This supports te idea that this metabolic route can be targeted for further drug design. Our previous studies have established that the first two enzymes of the ether lipid biosynthetic pathway in L. major, dihydroxyacetonephosphate acyltransferase LmDAT and alkyl dihydroxyacetonephosphate synthase LmADS, are implicated in the synthesis of the virulence factor lipophosphoglycan and cellular ether lipids, which play a crucial role in parasite pathogenesis. Our preliminary results have suggested that i) LmFAR is involved in the production of fatty alcohols which are essential for the synthesis of ether lipids, and ii) LmFAR is important for growth of the parasite. This proposal will test the central hypothesis that Leishmania peroxisomal fatty acyl-CoA reductase LmFAR is essential for ether lipid metabolism and generation of the virulence factor lipophosphoglycan, and consequently, for pathogenesis. To test this hypothesis, we propose to use two Specific Aims that combine a multidisciplinary approach that involves molecular biology, genetics, biochemistry, and cell biology techniques. In Specific Aim 1, we will investigate the enzymatic properties of LmFAR and its subcellular localization. In Specific Aim 2, we will assess the importance of LmFAR in ether lipid biosynthesis, virulence, and sensitivity to ether lipid-based drugs. Understanding the function of LmFAR is important for the development of novel strategies to prevent and treat Leishmania infections. In addition, this project will enhance the research environment at St. John's University by providing underprivileged students with numerous opportunities to learn the fundamentals of biomedical research.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    SC3
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
    75000
  • Indirect Cost Amount
    48750
  • Total Cost
    123750
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NIGMS:123750\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    ZGM1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ST. JOHN'S UNIVERSITY
  • Organization Department
    BIOLOGY
  • Organization DUNS
    073134744
  • Organization City
    QUEENS
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    114399000
  • Organization District
    UNITED STATES